Shafaq News/ Russia's leading respiratory doctor has quit over 'gross violations' of medical ethics that rushed through Putin's coronavirus 'vaccine'. According to Daily Mail, Professor Alexander Chuchalin quit the Russian health ministry's ethics council after making a fierce attack on the new Sputnik V drug ahead of the body approving its registration. Amid deep skepticism among Western experts over the drug, it appears that Chuchalin sought and failed to block its registration on 'safety' grounds before quitting the ethics council. He specifically accused the two leading medics involved in its development of flouting medical ethics in rushing the vaccine into production. Chuchalin allegedly asked them: 'Have you passed all the necessary paths approved by Russian Federation legislation and the international scientific community? Not! “This job has not been done. Thus, one of the ethical principles of medicine has been grossly violated to do no harm.” He stressed, “I am depressed by the position of some of our scientists who make irresponsible statements about ready-made vaccines.” Although specific reasons for his resignation were not given, in an interview with journal Nauka I Zhizn (Science and Life) shortly before he quit, Chuchalin warned, “In the case of a drug or vaccine, we, as ethical reviewers, would like to understand, first of all, how safe it is for humans.” “Safety always comes first. How to evaluate it? The vaccines that are being created today have never been used in humans, and we cannot predict how a person will tolerate it. The Russian vaccine, developed by the "Gamaleya" Research Institute and the Russian Ministry of Defense, is one of 28 vaccines that have reached the third stage, but the World Health Organization is including it in the first stage. The organization said in a statement that it is "in contact with Russian scientists and the Russian authorities and looks forward to reviewing the details of the experiments," adding that it "welcomes all developments in the ongoing research on vaccines against Covid-19 and in the field of vaccine development."